Guderma GmbH – Trademark Portfolio

Entity Type: 27

Guderma GmbH holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include FUßPUNKT.

Mergenthalerstr. 40

48268 Greven

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FUßPUNKT
FUßPUNKT
Registered 2022

Trademark Classifications

Guderma GmbH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Guderma GmbH have?

Guderma GmbH has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guderma GmbH file in?

Guderma GmbH files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Guderma GmbH's most well-known trademarks?

Guderma GmbH's registered trademark portfolio includes well-known marks such as FUßPUNKT. These are among 1 currently registered trademark in the portfolio.

What is Guderma GmbH's trademark registration success rate?

Guderma GmbH has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.